Search - tctmd.com

Displaying 101 - 120 of 177

Sort: Relevancy | Date

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

News Conference News ACC 2020

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

Michael O'Riordan

March 19, 2020

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

Core Competencies Defined for Echo, Cardiac CT in Structural Interventions

Yael L. Maxwell

December 03, 2019

News Conference News AHA 2019

Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques

Todd Neale

November 21, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Daily News

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

Todd Neale

September 19, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

Todd Neale

August 21, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

Advertisement

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

ISCHEMIA Questions? Some Answers From David Maron

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Core Competencies Defined for Echo, Cardiac CT in Structural Interventions

Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

TCTMD’s Top 10 Most Popular Stories for August 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content